Endotoxemia Correlates with Kidney Function and Length of Stay in Critically Ill Patients
Blood Purification · 2024
DOI: 10.1159/000534107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, 2024. Verfasst von Sian E Piret und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Medicine, Stony Brook University, Stony Brook, New York, USA. Hauptthemen laut MEDLINE: Endotoxemia, Acute Kidney Injury. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Introduction
Endotoxin is a key driver of sepsis, which frequently causes acute kidney injury (AKI). However, endotoxins may also be found in non-bacteremic critically ill patients, likely from intestinal translocation. Preclinical models show that endotoxins can directly injure the kidneys, and in COVID-19 patients, endotoxemia correlated with AKI. We sought to determine correlations between endotoxemia and kidney and hospital outcomes in a broad group of critically ill patients.
Methods
In this single-center, serial prospective study, 124 predominantly Caucasian adult patients were recruited within 48 h of admission to Stony Brook University Hospital Intensive Care Unit (ICU). Demographics, vital signs, laboratory data, and outcomes were collected. Circulating endotoxin was measured on days 1, 4, and 8 using the endotoxin activity assay (EAA). The association of EAA with outcomes was examined with EAA: (1) categorized as <0.6, ≥0.6, and nonresponders (NRs); and (2) used as a continuous variable.
Results
Patients with EAA ≥0.6 had a higher prevalence of proteinuria, and lower arterial oxygen saturation (SaO2) to fraction of inspired oxygen (FiO2) (SaO2/FiO2) ratio versus patients with EAA <0.6. EAA levels positively correlated with serum creatinine (sCr) levels on day 1. Patients whose EAA level stayed ≥0.6 had a slower decline in sCr compared to those whose EAA started at ≥0.6 and subsequently declined. Patients with AKI stage 1 and EAA ≥0.6 on day 1 showed slower decline in sCr compared to patients with stage 1 AKI and EAA <0.6. EAA ≥0.6 and NR patients had longer hospital stay and delayed ICU discharge versus EAA <0.6.
Conclusions
High EAA levels correlated with worse kidney function and outcomes. Patients whose EAA levels fell, and those with AKI stage I and day 1 EAA <0.6 recovered more quickly compared to those with EAA ≥0.6, suggesting that removal of circulating endotoxins may be beneficial in critically ill patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Medicine, Stony Brook University, Stony Brook, New York, USA.
- Spectral Medical Inc., Toronto, Ontario, Canada.
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Stony Brook University, Stony Brook, New York, USA.
- Division of Cardiology, Department of Medicine, Stony Brook University, Stony Brook, New York, USA.
- Renal Section, Northport VA Medical Center, Northport, New York, USA.
Zitieren
APA
Piret, S. E., Khan, S., Fairuz, F., Gholami, S., Davis, M., Kim, C. K., Espinoza, M., Foster, D., Kellum, J. A., Ahmad, S., Kalogeropoulos, A. P., & Mallipattu, S. K. (2024). Endotoxemia Correlates with Kidney Function and Length of Stay in Critically Ill Patients. Blood Purification. https://doi.org/10.1159/000534107
Vancouver
Piret SE, Khan S, Fairuz F, Gholami S, Davis M, Kim CK, et al. Endotoxemia Correlates with Kidney Function and Length of Stay in Critically Ill Patients. Blood Purification. 2024. doi:10.1159/000534107
BibTeX
@article{Piret2024,
author = {Piret, Sian E and Khan, Sobia and Fairuz, Fabliha and Gholami, Samaneh and Davis, Merin and Kim, Chang Kyung and Espinoza, Melissa and Foster, Debra and Kellum, John A and Ahmad, Sahar and Kalogeropoulos, Andreas P and Mallipattu, Sandeep K},
title = {Endotoxemia Correlates with Kidney Function and Length of Stay in Critically Ill Patients},
journal = {Blood Purification},
year = {2024},
doi = {10.1159/000534107}
}
EUVIMED